Literature DB >> 15613572

Does smoking in pregnancy modify the impact of antenatal steroids on neonatal respiratory distress syndrome? Results of the Epipage study.

A Burguet1, M Kaminski, P Truffert, A Menget, L Marpeau, M Voyer, J C Roze, B Escande, G Cambonie, J M Hascoet, H Grandjean, G Breart, B Larroque.   

Abstract

OBJECTIVES: To assess the relation between cigarette smoking during pregnancy and neonatal respiratory distress syndrome (RDS) in very preterm birth, and to analyse the differential effect of antenatal steroids on RDS among smokers and non-smokers.
DESIGN: A population based cohort study (the French Epipage study).
SETTING: Regionally defined births in France.
METHODS: A total of 858 very preterm liveborn singletons (27-32 completed weeks of gestation) of the French Epipage study were included in this analysis. The odds ratio for RDS in relation to smoking in pregnancy was estimated using a logistic regression to control for gestational age. The odds ratio for RDS in relation to antenatal steroids was estimated taking into account an interaction between antenatal steroids and cigarette smoking, using multiple logistic regression to control for gestational age, birthweight ratio, main causes of preterm birth, mode of delivery, and sex.
RESULTS: The odds ratio for RDS in relation to smoking in pregnancy adjusted for gestational age (aOR) was 0.59 (95% confidence interval (CI) 0.44 to 0.79). The aOR for RDS in relation to antenatal steroids was 0.31 (95% CI 0.19 to 0.49) in babies born to non-smokers and 0.63 (95% CI 0.38 to 1.05) in those born to smokers; the difference was significant (p = 0.04).
CONCLUSIONS: Cigarette smoking during pregnancy is associated with a decrease in the risk of RDS in very preterm babies. Although antenatal steroids reduce the risk of RDS in babies born to both smokers and non-smokers, the reduction is smaller in those born to smokers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15613572      PMCID: PMC1721825          DOI: 10.1136/adc.2003.041772

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  38 in total

1.  Very and moderate preterm births: are the risk factors different?

Authors:  P Y Ancel; M J Saurel-Cubizolles; G C Di Renzo; E Papiernik; G Bréart
Journal:  Br J Obstet Gynaecol       Date:  1999-11

2.  The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System.

Authors:  M S Kramer; K Demissie; H Yang; R W Platt; R Sauvé; R Liston
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

3.  The relationships between antenatal management, the cause of delivery and neonatal outcome in a large cohort of very preterm singleton infants.

Authors:  O Baud; V Zupan; T Lacaze-Masmonteil; F Audibert; T Shojaei; B Thebaud; Y Ville; R Frydman; M Dehan
Journal:  BJOG       Date:  2000-07       Impact factor: 6.531

Review 4.  Perinatal complications associated with maternal tobacco use.

Authors:  R L Andres; M C Day
Journal:  Semin Neonatol       Date:  2000-08

Review 5.  Interventions for promoting smoking cessation during pregnancy.

Authors:  J Lumley; S Oliver; E Waters
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 6.  Prophylactic corticosteroids for preterm birth.

Authors:  P Crowley
Journal:  Cochrane Database Syst Rev       Date:  2000

7.  Risk for respiratory distress syndrome in preterm infants born to mothers complicated by placenta previa.

Authors:  C Lin; S Wang; Y Hsu; Y Lin; T Yeh; F Chang
Journal:  Early Hum Dev       Date:  2001-01       Impact factor: 2.079

8.  Respiratory distress syndrome and maternal birth weight effects.

Authors:  T P Strandjord; I Emanuel; M A Williams; W M Leisenring; C Kimpo
Journal:  Obstet Gynecol       Date:  2000-02       Impact factor: 7.661

9.  Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes.

Authors:  S T Vermillion; D E Soper; M L Bland; R B Newman
Journal:  Am J Obstet Gynecol       Date:  2000-10       Impact factor: 8.661

Review 10.  Smoking and pediatric respiratory health.

Authors:  J P Joad
Journal:  Clin Chest Med       Date:  2000-03       Impact factor: 2.878

View more
  6 in total

1.  Tobacco smoke in infants with bronchopulmonary dysplasia.

Authors:  Stéphanie Martinez; Patricia Garcia-Meric; Véronique Millet; Mellie Aymeric-Ponsonnet; Khuder Alagha; Jean-Christophe Dubus
Journal:  Eur J Pediatr       Date:  2015-01-30       Impact factor: 3.183

2.  Mimicking maternal smoking and pharmacotherapy of preterm labor: fetal nicotine exposure enhances the effect of late gestational dexamethasone treatment on noradrenergic circuits.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2011-08-19       Impact factor: 4.077

3.  Steroid hormone levels associated with passive and active smoking.

Authors:  Offie P Soldin; Kepher H Makambi; Steven J Soldin; Daniel M O'Mara
Journal:  Steroids       Date:  2011-03-17       Impact factor: 2.668

4.  Thyroid hormone levels associated with active and passive cigarette smoking.

Authors:  Offie P Soldin; Bethany E Goughenour; Sappho Z Gilbert; Helain J Landy; Steven J Soldin
Journal:  Thyroid       Date:  2009-08       Impact factor: 6.568

5.  Heart rate variability in preterm infants and maternal smoking during pregnancy.

Authors:  Gérard Thiriez; Malika Bouhaddi; Laurent Mourot; François Nobili; Jacques-Olivier Fortrat; Alain Menget; Patricia Franco; Jacques Regnard
Journal:  Clin Auton Res       Date:  2009-03-03       Impact factor: 4.435

6.  Respiratory Outcome of the Former Premature Infants.

Authors:  Raluca Daniela Bogdan; Lidia Rusu; Adrian Ioan Toma; Leonard Nastase
Journal:  J Med Life       Date:  2019 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.